{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"7.780","rs_stock_flag":false,"fiscal_year_end":"2024年12月31日","hist_closedate":"2025年9月25日","replication_method":null,"amt_os":"316,138,689","primaryexch":"香港交易所","ric":"2179.HK","product_subtype":null,"db_updatetime":"2025年9月28日08:06","mkt_cap_u":"B","am_u":"K","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":0.0,"inline_upper_strike_price":"","sedol":"BLF9BM7","am":"117.28","iv":"","ew_strike":"","as":"7.600","geographic_focus":null,"incorpin":"中華人民共和國","etp_baseCur":null,"ew_amt_os":"","bd":"7.250","registrar":"香港中央證券登記有限公司","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"500","update_time":"2025-09-28 00:06:03.0","lo52":"6.510","shares_issued_date":"2025年8月31日","premium":"","strike_price_ccy":null,"yield":"","vo_u":"K","base_currency":null,"coupon":"","expiry_date":"","chairman":"劉勇","underlying_ric":"2179.HK","hi52":"9.800","issuer_name":"江蘇瑞科生物技術股份有限公司 - B - H股","h_share_flag":false,"ew_sub_per_from":"","div_yield":"","interest_payment_date":"-","updatetime":"2025年9月26日16:08","aum_date":"","lo":"7.160","mkt_cap":"2.40","f_aum_hkd":null,"ew_sub_per_to":"","ls":"7.600","nav_date":"","csic_classification":null,"floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"醫療保健業 - 藥品及生物科技","ew_desc":null,"inception_date":"","nc":"+0.110","aum":"","issued_shares_class_B":null,"vo":"15.50","secondary_listing_flag":false,"listing_date":"2022年3月31日","issued_shares_class_A":null,"as_at_label":"截至","ew_amt_os_dat":"","nm":"江蘇瑞科生物技術股份有限公司 - B - H股","nm_s":"瑞科生物－Ｂ","sym":"2179","inline_lower_strike_price":"","listing_category":"主要上市","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.010","strike_price":"","summary":"江蘇瑞科生物技術股份有限公司是一家從事疫苗研發的中國公司。該公司尚處於研發階段。該公司的疫苗管線包括重組九價人乳頭瘤病毒（HPV）、新佐劑重組九價HPV疫苗、重組二價（16/18）HPV疫苗、重組二價（6/11）HPV疫苗、新佐劑重組四價HPV疫苗、新佐劑重組帶狀疱疹病疫苗、新佐劑重組呼吸道合胞病毒疫苗、重組偏肺病毒疫苗、重組人巨細胞病毒疫苗、重組雙組分新冠病毒疫苗、重組乙型肝炎病毒疫苗等。","op":"7.420","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"生物技術","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"中國泰州市<br/>醫藥高新區<br/>藥城大道888號","pc":"+1.47","days_to_expiry":null,"underlying_code":null,"pe":"","eps_ccy":"RMB","hdr":false,"launch_date":"","hc":"7.490","isin":"CNE1000057K9","moneyness":""}},"qid":"1759075020765"}
